BioSpace News Archive

Business

Juntendo University, Sysmex, and ThinkCyte Collaborate to Advance the Early Detection and Treatment of Blood Cancer

Juntendo University, Sysmex Corporation, and ThinkCyte K.K. have announced a collaborative research partnership to advance the early detection and treatment of chronic myelogenous leukemia (CML).

April 18, 2023

·

5 min read

BioMidwest

Philips Future Health Index 2023 global report: healthcare leaders focused on addressing staff shortages, with the support of more AI investments

Royal Philips, a global leader in health technology, announced the results of its Future Health Index 2023 report: Taking healthcare everywhere.

April 18, 2023

·

3 min read

Pharm Country

U.S. Food and Drug Administration Accepts for Priority Review Taiho Oncology’s Supplemental New Drug Application for the Use of Trifluridine/Tipiracil (LONSURF®) in Combination With Bevacizumab for Refractory Metastatic Colorectal Cancer (mCRC)

Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental new drug application (sNDA) for trifluridine/tipiracil (LONSURF®) as monotherapy or in combination with bevacizumab.

April 18, 2023

·

13 min read

BioSyent to Present at 2023 Bloom Burton & Co. Healthcare Investor Conference

BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2023 Bloom Burton & Co. Healthcare Investor Conference.

April 18, 2023

·

2 min read

Biotech Bay

Aerin Medical Supports AAO-HNS Position Recognizing Nasal Valve Repair as a Distinct Procedure that Improves Nasal Obstruction Symptoms

Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, supports the recent American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) position statement.

April 18, 2023

·

4 min read

Genetown

Landmark Study Finds Pison AI Technology Can Detect Neurological Disorder in ALS Patients

Pison, the pioneers behind AI-powered neural biosensors for health, wellness, and 3D touchless smart device control, today announced the results of recent clinical trial conducted by researchers at the Lewis Katz School of Medicine at Temple University’s MDA/ALS Center of Hope.

April 18, 2023

·

5 min read

BioMidwest

Monteris Medical Announces Publication of Largest Series of NeuroBlate Laser Interstitial Thermal Therapy for Biopsy-Proven Radiation Necrosis

Monteris Medical announced today that a new publication on laser interstitial thermal therapy (LITT) using the NeuroBlate® System to treat patients with radiation necrosis (RN) has been published in the journal, Neuro-Oncology Advances.

April 18, 2023

·

4 min read

Drug Development

Nascent Submits Phase 2 Clinical Research Protocol to FDA for Review and Approval

Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage biotechnology Company whose business is focused in the brain cancer space, announced today that the Protocol for the Phase 2 clinical trials was submitted to the FDA for review and approval.

April 18, 2023

·

2 min read

Cosmetic Bioactive Ingredients Market Growth 5.4% CAGR to 2028 Dominated by Amino Acids held Market Share of 20.81% in 2021 – The Insight Partners

The Insight Partners published latest research report on “Cosmetic Bioactive Ingredients Market Growth Report, Size, Share Forecast to 2028 - COVID-19 Impact and Global Analysis By Ingredient Type, Sources and Geography,”

April 18, 2023

·

8 min read

Pharm Country

Why Do Children Develop Type 2 Diabetes? $4.1 Million NIH Grant Will Help Montefiore Einstein Researchers Investigate

Type 2 diabetes is surging among U.S. children. The number of youths under age 20 living with the disease has nearly doubled between 2001 and 2017, and yet—aside from increases in childhood obesity—the reasons for this disturbing increase are not clear.

April 18, 2023

·

5 min read